国内首个口服GLP-1类减肥药获批上市,由礼来申报,商品名叫穆优达

红星资本局
Nov 12

红星资本局11月12日消息 12日,国家药监局官网显示,礼来申报的1类创新药奥氟格列隆钙片(商品名称:穆优达)获批上市。该药品适用于在控制饮食和增加运动基础上,用于肥胖或超重并伴有至少一种体重相关合并症的成人体重管理。 ▲国家药监局官网截图  礼来11月12日表示,在临床研究中,奥氟格列隆展现出代谢相关指标的积极改善。在肥胖症人群ATTAIN-1临床研究中,接受最高剂量奥氟格列隆治疗并持续治疗72...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10